Biotech entrepreneurs grow a new CRO in China

Biotech entrepreneur John Oyler--who helped found Genta and Galanea--sat down with Chemistry World to discuss his three-year-old CRO, BioDuro. He and an old friend founded the CRO with their own money, choosing to base the contract research organization in Beijing rather than Shanghai, where the big multinational drug companies have flocked.

"By the end of this year, we will have nearly 600 chemists and biologists working for the company," Oyler tells the pub. "Most of the world's top pharmaceutical firms are our clients. We have our business and marketing headquarters in San Diego, California. We have a team of more than 20 senior scientists leading the firm, many of whom used to be at multinationals like Merck and Pfizer."

- read the report in Chemistry World

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.